Skip to main content Skip to main navigation menu Skip to site footer

Relationship between CD4 levels and mucocutaneous manifestations in HIV-AIDS patients at Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia

  • Damayanti ,
  • Citra Dwi Harningtyas ,
  • Maylita Sari ,
  • Muhammad Yulianto Listiawan ,
  • Diah Mira Indramaya ,
  • Linda Astari ,
  • Budi Utomo ,
  • Dwi Murtiastutik ,
  • Setyana Widyantari ,
  • Astindari ,
  • Afif Nurul Hidayati ,

Abstract

Background: CD4 can assess the immune status of a patient with HIV, and this is considered the standard way of assessing and characterizing the severity of HIV-related immunodeficiency. CD4 cell counts are associated with increased mucocutaneous manifestations. This study aims to explain the relationship between CD4 and mucocutaneous manifestations in HIV-AIDS   patients.

Methods: This study is analytical with a retrospective cross-sectional design. The data of the present study was obtained from a number of 614 HIV-AIDS patients with mucocutaneous manifestations, but only 149 patients met the inclusion criteria, including the CD4 level data.

Results: The majority of the patients in this study were male (74.5%), which includes patients under the age group of 25-49 years (70.5%). The most common risk factor was heterosexuality (48.3%). Most CD4 levels were in the CD4 group < 200 (64.4%). Based on the distribution of mucocutaneous manifestations, the various cases were reported as infections (55.8%). Pyoderma and syphilis were significantly associated with CD4 counts ≥ 200 cells/mm3 with a risk of 3.7 and 7.8 times than CD4 cells < 200 cells / mm3. On the other hand, candidiasis was higher in CD4 count < 200 cells/mm3 with a significant difference and a risk of 0.3 times compared to CD4 count ≥ 200 cells/mm3.

Conclusion: Several mucocutaneous manifestations can be considered predictors of advanced immunosuppression (low CD4 level), which were pyoderma, syphilis, and candidiasis in this study.

References

  1. Lipworth AD, Freeman EE, Saavedra AP. Cutaneous Manifestations of HIV and Human T-Lymphotropic Virus. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS. eds. Fitzpatrick's Dermatology, 9e. McGraw Hill; 2019.
  2. Chopra S, Arora U. Skin and Mucocutaneous Manifestations: Useful Clinical Predictors of HIV/AIDS. J Clin Diagn Res. 2012;6(10):1695-1698. doi:10.7860/JCDR/2012/4615.2633.
  3. Raju PV, Rao GR, Ramani TV, Vandana S. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol. 2005;44(8):646-649. doi:10.1111/j.1365-4632.2004.02067.x.
  4. Azfar NA, Khan AR, Zia MA, Humayun A, Malik LM, Jahangir M. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Assoc Dermatol. 2011;21(3):149-153. doi: 10.20473/bikk.V33.3.2021.156-161.
  5. Botting RA, Rana H, Bertram KM, et al. Langerhans cells and sexual transmission of HIV and HSV. Rev Med Virol. 2017;27(2):10.1002/rmv.1923. doi:10.1002/rmv.1923.
  6. Shoko C, Chikobvu D. A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy. BMC Infect Dis. 2019;19(1):169. Published 2019 Feb 15. doi:10.1186/s12879-019-3781-1.
  7. Crum-Cianflone N, Hullsiek KH, Satter E, et al. Cutaneous malignancies among HIV-infected persons. Arch Intern Med. 2009;169(12):1130-1138. doi:10.1001/archinternmed.2009.104.
  8. Mirnezami M, Zarinfar N, Sofian M, Botlani Yadegar B, Rahimi H. Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts. Scientifica (Cairo). 2020;2020:7503756. Published 2020 Aug 11. doi:10.1155/2020/7503756.
  9. Moustaide K, Nassiri A, BayBay H, Gallouj S, Rabhi S, Mernissi FZ. Profile of dermatological manifestations in seropositive patients correlated with CD4 count sample of a Moroccan population. Yumed Text. 2019;1(1):1-6.
  10. Adewole OE, Olagundoye OA, Ajumobi IO. Depression and its associated factors among people living with HIV/AIDS attending the HIV/AIDS CLINIC in Southwest Nigeria. Family Medicine & Primary Care Review. 2021;23(1):7-12. doi:10.5114/fmpcr.2021.103149.
  11. Agrawal M, Sharma P, Saxena A, A study of sexually transmitted infections among HIV – infected patients in correlation with their CD4 T cell counts. IP Indian J Clin Exp Dermatol 2020;6(3):257-260. https://doi.org/10.18231/j.ijced.2020.052.
  12. Khat N, Kudligi C, Rathod RM, Kuntoji V. A clinical study of mucocutaneous manifestation of HIV/AIDS and its correlation with CD4 count. Journal of Pakistan Association of Dermatologists. 2020;30(4):550-557.
  13. Pudjiati SR, Dewi NA, Palupi SSA. Correlation between CD4 cell counts with mucocutaneous manifestations: study of HIV patients in Dr. Sardjito General Hospital, Yogyakarta. J the Med Sci. 2018;50(1):42–9. https://doi.org/10.19106/JMedSci005001201805.
  14. Khondker L. Dermatological manifestations of HIV/AIDS patients. J Enam Med Coll. 2018;9(3):185–8. doi:https://doi.org/10.3329/jemc.v9i3.43249.
  15. Fernandes MS, Bhat RM. Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count. Int J STD AIDS. 2015;26(6):414-419. doi:10.1177/0956462414543121.
  16. Titou H, Ebongo C, Hjira N. Dermatologic manifestations among human immunodeficiency virus patients in Morocco and association with immune status. Int J Dermatol. 2018;57(2):156-161. doi:10.1111/ijd.13864.
  17. Boushab BM, Malick Fall FZ, Ould Cheikh Mohamed Vadel TK, et al. Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania. Int J Dermatol. 2017;56(12):1421-1424. doi:10.1111/ijd.13737.
  18. Harnanti DV, Hidayati AN, Miftahussurur M. Concomitant Sexually Transmitted Diseases In Patients With Diagnosed Hiv/Aids: A Retrospective Study. Afr J Infect Dis. 2018;12(1 Suppl):83-89. Published 2018 Mar 7. doi:10.2101/Ajid.12v1S.12.
  19. Abhinandan HB, Suresh KJ, Asha N, Ramesh K, Manali J, Jitendra B et al. Cutaneous manifestations of HIV-infection in relation with CD4 cell counts in Hadoti region. J Evol Med Dent Sci. 2013;2(36):6703-14. doi:10.14260/jemds/1246.
  20. Tahir K., Alam F, Hussain I, Ashraf S. Frequency of mucocutaneous manifestations in HIV positive patients. J Pak Assoc Dermatol. 2018;28(4):420–5.
  21. Li YY, Yang SH, Wang RR, Tang JT, Wang HM, Kuang YQ. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China. Int J Dermatol. 2020;59(3):308-313. doi:10.1111/ijd.14725.
  22. Bayu R, Indrawan I, Sukarni N, Sridana M. Profil pasien baru HIV di poliklinik VCT BRSU Tabanan Bali pada tahun 2009 sampai 2017. Intisari Sains Medis. 2018;9(1). doi:10.15562/ism.v9i1.145.

How to Cite

Damayanti, Citra Dwi Harningtyas, Maylita Sari, Muhammad Yulianto Listiawan, Diah Mira Indramaya, Linda Astari, Budi Utomo, Dwi Murtiastutik, Setyana Widyantari, Astindari, & Afif Nurul Hidayati. (2022). Relationship between CD4 levels and mucocutaneous manifestations in HIV-AIDS patients at Dr. Soetomo General Academic Teaching Hospital, Surabaya, Indonesia. Bali Medical Journal, 11(1), 216–222. https://doi.org/10.15562/bmj.v11i1.3416

HTML
0

Total
0

Share

Search Panel